Company or ticker...

CG Oncology

CG Oncology develops bladder cancer therapies, including oncolytic immunotherapy.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

CGON

6.3B

1,251.6

n/a

74.70%

Key Facts

M. Cap

PS

PE

YTD

6.3B

1,251.6

n/a

74.70%

10MA

20MA

50MA

200MA

$CGON